登录
 机构网站
  1. 首页
  2. 情报产品
  3. 快讯详情

《LANCET，3月13日，COVID-19, ECMO, and lymphopenia: a word of caution》

  • 来源专题：COVID-19科研动态监测
  • 编译者： xuwenwhlib
  • 发布时间：2020-03-14

  • COVID-19, ECMO, and lymphopenia: a word of caution

    Brandon Michael Henry

    Published:March 13, 2020DOI:https://doi.org/10.1016/S2213-2600(20)30119-3

    Extracorporeal membrane oxygenation (ECMO) can serve as life-saving rescue therapy for refractory respiratory failure in the setting of acute respiratory distress syndrome, such as that induced by coronavirus disease 2019 (COVID-19). In the study by Yang and colleagues,1 who compared clinical characteristics and outcomes in patients with severe COVID-19, five (83%) of six patients receiving ECMO died. Although this sample was small, and specific baseline characteristics and disease courses were almost unknown, it raises concerns about potential harms of ECMO therapy for COVID-19.

  • 原文来源：https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30119-3/fulltext
20浏览量
原文链接
相关报告

  • 《LANCET，3月13日，COVID-19, a pandemic or not?》
    • 来源专题：COVID-19科研动态监测
    • 编译者：zhangmin
    • 发布时间：2020-03-14
    • COVID-19, a pandemic or not? The Lancet Infectious Diseases Published:March 13, 2020DOI:https://doi.org/10.1016/S1473-3099(20)30180-8 The current outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread, and as of March 11, 2020, it has reached 115 countries, with 119?239 cases and 4287 deaths. In January, WHO decided to define the outbreak of COVID-19 as a public health emergency of international concern, which triggered the release of funding and other resources. Despite SARS-CoV-2 now being present in every continent apart from Antartica, WHO remains reluctant to make the next step and call the outbreak a pandemic.
    47浏览量
    原文链接

  • 《MedRxiv，4月11日，BCG protects against COVID-19? A word of caution》
    • 来源专题：COVID-19科研动态监测
    • 编译者：xuwenwhlib
    • 发布时间：2020-04-12
    • BCG protects against COVID-19? A word of caution Reka Szigeti, Domos Kellermayer, View ORCID ProfileRichard Kellermayer doi: https://doi.org/10.1101/2020.04.09.20056903 Abstract The COVID-19 pandemic, caused by type 2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2), puts all of us to the test. Epidemiologic observations could critically aid the development of protective measures to combat this devastating viral outbreak. A recent publication, linked nation based universal Bacillus Calmette-Guerin (BCG) vaccination to potential protection against morbidity and mortality from SARS-CoV-2, and received much attention in public media, even before its peer review. We wished to validate the findings by examining the association between daily rates of COVID-19 case fatality (i.e. Death Per Case /Days of the endemic [dpc/d]) and the presence of universal BCG vaccination before 1980, or the year of the establishment of universal vaccination. There was no significant association in either analysis. In this work we emphasize caution amidst the publication surge on COVID-19, and highlight the political/economical-, arbitrary selection-, and fear/anxiety related biases, which may obscure scientific rigor. It is underscored that physical (social) distancing (i.e. quarantine) and use of personal protective equipment (PPE) are the only epidemiologic measures (Iceland being a great example, where universal BCG vaccination policy was never in place), which consistently associate with successful counteraction of morbidity and mortality during the pandemic. *注，本文为预印本论文手稿，是未经同行评审的初步报告，其观点仅供科研同行交流，并不是结论性内容，请使用者谨慎使用.
    67浏览量
    原文链接